Industry Updates
GSK’s Arexvy vaccine for RSV is approved for Malaysian seniors
GlaxoSmithKline (GSK) announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for RSV (respiratory syncytial virus). The RSV vaccine has …
RSV
Cilisos Media Sdn. Bhd. [201401011719 (1087796-H)] Copyright © 2020. All Rights Reserved